title: Proliferation of PTEN-deficient haematopoietic tumour cells is not affected by isoform-selective inhibition of p110 PI3-kinase and requires blockade of all class 1 PI3K activity.
authors.forename: Chloe
authors.initials: C
authors.lastname: Stengel
authors.forename: Emma
authors.initials: E
authors.lastname: Jenner
authors.forename: Koremu
authors.initials: K
authors.lastname: Meja
authors.forename: Saloni
authors.initials: S
authors.lastname: Mayekar
authors.forename: Asim
authors.initials: A
authors.lastname: Khwaja
mesh_terms: D049109:Cell Proliferation; D058534:Class I Phosphatidylinositol 3-Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D019337:Hematologic Neoplasms / Q000188:drug therapy* / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D051059:PTEN Phosphohydrolase / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*
chemical_list: D058534:Class I Phosphatidylinositol 3-Kinases; D051059:PTEN Phosphohydrolase; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors; C497132:PIK3CB protein, human; C494929:PTEN protein, human
keywords: PI3-kinase; PTEN; T-ALL; myeloma; p110β